Tevogen Inc (TVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -56,846 | -52,941 | -30,756 | 4,408 | 1,794 |
| Depreciation Amortization | 278 | 184 | 91 | N/A | N/A |
| Accounts payable and accrued liabilities | 765 | 373 | 498 | N/A | N/A |
| Other Working Capital | 361 | -70 | 56 | 738 | 539 |
| Other Operating Activity | 49,248 | 48,059 | 27,935 | -5,362 | -2,534 |
| Operating Cash Flow | $-6,195 | $-4,395 | $-2,177 | $-215 | $-202 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -133 | -133 | -133 | N/A | N/A |
| Investing Cash Flow | $-133 | $-133 | $-133 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,650 | 2,500 | 2,500 | N/A | 0 |
| Other Financing Activity | -200 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $3,450 | $2,500 | $2,500 | $N/A | $0 |
| Beginning Cash Position | 5,484 | 5,484 | 5,484 | 345 | 345 |
| End Cash Position | 2,607 | 3,457 | 5,674 | 129 | 143 |
| Net Cash Flow | $-2,878 | $-2,028 | $190 | $-215 | $-202 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,195 | -4,395 | -2,177 | -215 | -202 |
| Capital Expenditure | -133 | -133 | -133 | N/A | N/A |
| Free Cash Flow | -6,328 | -4,528 | -2,310 | -215 | -202 |